🇺🇸 FDA
Patent

US 8329141

Locoregional internal radionuclide ablation of abnormal tissues

granted A61KA61K51/02

Quick answer

US patent 8329141 (Locoregional internal radionuclide ablation of abnormal tissues) held by The Board of Regents of the University of Texas System expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
55
CPC classes
A61K, A61K51/02